enVVeno Medical Corp Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- enVVeno Medical Corp stock issued during period, value, new issues for the quarter ending 2024-12-31 was $0.00.
- enVVeno Medical Corp stock issued during period, value, new issues for the quarter ending 2024-09-30 was $13.59M.
- enVVeno Medical Corp stock issued during period, value, new issues for the quarter ending 2021-06-30 was $37.58K, a 98.10% decline year-over-year.
- enVVeno Medical Corp stock issued during period, value, new issues for the quarter ending 2021-03-31 was $38.13M, a 156773.07% increase year-over-year.
- enVVeno Medical Corp stock issued during period, value, new issues for fiscal 2024 was $13.59M, a 47.30% decline from fiscal 2023.
- enVVeno Medical Corp stock issued during period, value, new issues for fiscal 2023 was $25.79M.
- enVVeno Medical Corp stock issued during period, value, new issues for fiscal 2021 was $38.13M, a 287.17% increase from fiscal 2020.
- enVVeno Medical Corp stock issued during period, value, new issues for fiscal 2020 was $9.85M, a 324.98% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $13.59M 10-K · filed 2026-03-26 |
| 2024-09-30 | $13.59M 10-Q · filed 2024-10-31 | |
| 2023-12-31 | $25.79M 10-K · filed 2025-02-28 | |
| 2021-12-31 | $38.13M 10-K · filed 2023-03-02 | |
| 2021-06-30 | $37.58K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $38.13M 10-Q · filed 2022-10-27 | |
| 2020-12-31 | $9.85M 10-K · filed 2022-03-28 | |
| 2020-06-30 | $1.97M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $24.30K 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $2.32M 10-K · filed 2021-03-31 | |
| 2019-06-30 | $3.32M 10-Q · filed 2019-10-31 | $5.65M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $2.32M 10-Q · filed 2020-08-14 | $8.40M derived: sum of 4 quarters · filed 2020-08-14 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-18 | $6.08M 10-K · filed 2020-03-18 |
| 2018-09-30 | $12.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | |
| 2018-06-30 | $6.07M 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |